Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4Q9F3
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0008104 | protein localization | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0015031 | protein transport | 4 | 12 |
GO:0033036 | macromolecule localization | 2 | 12 |
GO:0045184 | establishment of protein localization | 3 | 12 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0051641 | cellular localization | 2 | 12 |
GO:0070727 | cellular macromolecule localization | 3 | 12 |
GO:0071702 | organic substance transport | 4 | 12 |
GO:0071705 | nitrogen compound transport | 4 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.276 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.286 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.635 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.355 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.610 |
DOC_CKS1_1 | 175 | 180 | PF01111 | 0.459 |
DOC_CKS1_1 | 239 | 244 | PF01111 | 0.499 |
DOC_MAPK_gen_1 | 18 | 27 | PF00069 | 0.246 |
DOC_PP2B_LxvP_1 | 245 | 248 | PF13499 | 0.481 |
DOC_PP4_MxPP_1 | 250 | 253 | PF00568 | 0.489 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.570 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 238 | 243 | PF00397 | 0.495 |
LIG_14-3-3_CanoR_1 | 168 | 176 | PF00244 | 0.419 |
LIG_14-3-3_CanoR_1 | 45 | 49 | PF00244 | 0.493 |
LIG_APCC_ABBA_1 | 80 | 85 | PF00400 | 0.475 |
LIG_BRCT_BRCA1_1 | 10 | 14 | PF00533 | 0.604 |
LIG_Clathr_ClatBox_1 | 51 | 55 | PF01394 | 0.577 |
LIG_eIF4E_1 | 77 | 83 | PF01652 | 0.542 |
LIG_FHA_1 | 120 | 126 | PF00498 | 0.475 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.537 |
LIG_LIR_Apic_2 | 174 | 179 | PF02991 | 0.419 |
LIG_LIR_Apic_2 | 243 | 249 | PF02991 | 0.544 |
LIG_LIR_Gen_1 | 152 | 161 | PF02991 | 0.500 |
LIG_LIR_Gen_1 | 75 | 84 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 11 | 17 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 75 | 80 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.473 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.526 |
LIG_PTB_Apo_2 | 157 | 164 | PF02174 | 0.500 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.577 |
LIG_SH2_NCK_1 | 176 | 180 | PF00017 | 0.577 |
LIG_SH2_NCK_1 | 254 | 258 | PF00017 | 0.572 |
LIG_SH2_PTP2 | 246 | 249 | PF00017 | 0.569 |
LIG_SH2_SRC | 246 | 249 | PF00017 | 0.569 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.610 |
LIG_SH3_1 | 246 | 252 | PF00018 | 0.575 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.668 |
LIG_SH3_3 | 246 | 252 | PF00018 | 0.609 |
LIG_SUMO_SIM_par_1 | 50 | 55 | PF11976 | 0.577 |
LIG_UBA3_1 | 51 | 56 | PF00899 | 0.475 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.494 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.559 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.555 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.550 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.523 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.493 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.658 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.371 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.367 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.575 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.570 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.599 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.525 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.300 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.576 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.475 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.500 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.430 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.444 |
MOD_NEK2_1 | 210 | 215 | PF00069 | 0.505 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.439 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.475 |
MOD_PIKK_1 | 40 | 46 | PF00454 | 0.555 |
MOD_PKA_1 | 8 | 14 | PF00069 | 0.482 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.419 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.436 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.493 |
MOD_Plk_1 | 136 | 142 | PF00069 | 0.478 |
MOD_Plk_1 | 154 | 160 | PF00069 | 0.524 |
MOD_Plk_1 | 161 | 167 | PF00069 | 0.434 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.491 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.419 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.500 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.459 |
MOD_ProDKin_1 | 238 | 244 | PF00069 | 0.494 |
MOD_SUMO_rev_2 | 110 | 120 | PF00179 | 0.544 |
TRG_DiLeu_BaLyEn_6 | 257 | 262 | PF01217 | 0.491 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.634 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.542 |
TRG_ER_diArg_1 | 61 | 64 | PF00400 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVR2 | Leptomonas seymouri | 82% | 100% |
A0A0S4IPS2 | Bodo saltans | 46% | 100% |
A0A1X0P8G8 | Trypanosomatidae | 56% | 100% |
A0A3Q8IDL4 | Leishmania donovani | 93% | 100% |
A0A422N7B4 | Trypanosoma rangeli | 58% | 99% |
A4HEP4 | Leishmania braziliensis | 88% | 100% |
A4I1X4 | Leishmania infantum | 92% | 100% |
D0A1V0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 96% |
E9AY20 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
P53843 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 90% |
P53990 | Homo sapiens | 32% | 73% |
Q3ZBV1 | Bos taurus | 31% | 73% |
Q54I39 | Dictyostelium discoideum | 29% | 72% |
Q568Z6 | Rattus norvegicus | 32% | 73% |
Q5R6G8 | Pongo abelii | 31% | 73% |
Q9CX00 | Mus musculus | 32% | 74% |
V5DIL5 | Trypanosoma cruzi | 57% | 100% |